medical imaging
Today is International Clinical Trials Day. Let’s celebrate this event and raise awareness about clinical trials while expressing our gratitude to all clinical research professionals worldwide.
Investigator-Initiated Trials (IITs) are pivotal in medical research, driven by independent investigators to explore new avenues and innovative medical approaches. These trials contribute significantly to advancing medical knowledge.
At mediri, we take pride in supporting researchers and clinicians in their IITs. With our expertise in imaging, we provide crucial assistance for these trials.
If you’re interested in learning more about our work or are involved in IITs, feel free to reach out to us.
We see a rapidly increasing need for medical imaging in clinical trials and in the development of standardized imaging biomarkers. In 2022, more than 1900 clinical trials were registered in Germany. In many of them, medical imaging is used in as a primary, quantitative and surrogate biomarker.
New AI developments across the healthcare industry, with radiology at the forefront, continue to increase the need for medical imaging core lab services.
As an Imaging CRO and Core Lab, we make your image-based clinical trials more efficient, faster and safer. This is especially important when it comes to multi-center studies that place high demands on comparability of image data.
Contact us to discuss our medical imaging solutions for reliable clinical trial results.
New office. New Neighbours. New view.
It’s done! We have offically moved to Am Taubenfeld 21/1 in 69123 Heidelberg.
Have you read one of the latest publications on iron rim lesions in multiple sclerosis by our research partners at the Universitätsmedizin Mannheim? The authors around Prof. Achim Gass conclude that iron rim lesions are associated with higher intrathecal immunoglobin G synthesis. Furthermore, CSF-mediated intrathecal smouldering inflammation could explain a CSF-related gradient of tissue damage.
Read the publication here.
After a successful member audit we are excited to be a part of the Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA). We are looking forward to our first general meeting in Cologne and the networking opportunities.
Want to know more about BVMA? Click here: https://www.bvma.de/
We proudly announce that the ASPIRE team has a new member: Darmstadt University of Applied Sciences joins the consortium and brings in expertise for AI-based brain image analysis and atlas creation. Together we will establish a platform independent dementia diagnosis support based on arterial spin labeling images.
We proudly announce the release of our new mTRIAL version. For the first time it incorporates a webbased comprehensive DICOM image viewer for platform independent and real time access of clinical trial data. Central read workflow planning and execution has been upgraded for even more reliable and efficient review of radiological data. mTRIAL 3.4. – ready to support your next image based clinical trial.
We proudly announce that mediri has been awarded as Digital Innovator 2023 in the category „medical technology and pharmaceuticals“ by CHIP. In times of digitization, CHIP and data analysis specialist Globis Consulting have studied the innovative power of German companies and institutes in digitization. CHIP is known as one oft the top recommendation brands.
See the full ranking here.
If you have two minutes, take a look at this aerzteblatt article about artificial intelligence that is mentioning mediri and the DeepRAY project.